Publication Topic : Access to Medicines

Don’t Trade Away Health: Brief to Canada’s Minister of International Trade Regarding the Trans‐Pacific Partnership Negotiations and Access to Medicines

Billions of people around the world lack access to life‐saving medicines. While this is because of a number of synergistic causes, one critical factor is the prohibitively high cost of patent‐monopolized medications. Provisions currently being negotiated for the Trans‐Pacific Partnership agreement (TPP) risk exacerbating this situation, which for many is a matter of life and … Read more

Letter to Canadian Minister of International Trade re: Trans‐Pacific Partnership (TPP) Agreement and safeguarding access to medicines

“We, the undersigned civil society organizations, write to you in order to express our deep concern with some of the provisions proposed for the intellectual property, pharmaceutical pricing and investment chapters of the Trans‐Pacific Partnership agreement (TPP). We are concerned that the measures currently being considered could lead to an agreement that would hamper the ability of millions … Read more

Annual Report 2012–2013

Our latest annual report highlights our work between April 1, 2012 and March 31, 2013.

Civil society letter to members of the World Trade Organization re: a further extension of the transition period for Least Developed Countries under article 66.1 of the TRIPS agreement

“As civil society organisations concerned with access to medicines, to educational resources, to environmentally sound technologies, and to other public goods and cultural creations and further concerned with farmers’ rights, food security, human flourishing, sustainable and equitable technological and industrial development in Least Developed Countries (LDCs), we call on WTO Members to unconditionally accord the … Read more

Fixing Canada’s Access to Medicines Regime (CAMR): 20 Questions & Answers

In this document: Questions 1 to 4 give a quick overview of CAMR and why it needs to be fixed. Questions 5 to 11 provide more in-depth, background information. Questions 12 to 14 explain the solution for fixing CAMR. Questions 15 to 20 respond to some of the main objections to reforming CAMR. Updated October … Read more